{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:27:36Z","timestamp":1779236856045,"version":"3.51.4"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2020,6,8]],"date-time":"2020-06-08T00:00:00Z","timestamp":1591574400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,8]],"date-time":"2020-06-08T00:00:00Z","timestamp":1591574400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100006109","name":"Vedeck\u00e1 Grantov\u00e1 Agent\u00fara M\u0160VVa\u0160 SR a SAV","doi-asserted-by":"publisher","award":["VEGA 1\/0112\/17"],"award-info":[{"award-number":["VEGA 1\/0112\/17"]}],"id":[{"id":"10.13039\/501100006109","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s40266-020-00772-z","type":"journal-article","created":{"date-parts":[[2020,6,8]],"date-time":"2020-06-08T05:04:05Z","timestamp":1591592645000},"page":"595-604","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Factors Associated with Reinitiation of Statin Treatment in Older Patients with Peripheral Arterial Disease"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7672-1574","authenticated-orcid":false,"given":"Martin","family":"Wawruch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"Gejza","family":"Wimmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Murin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Paduchova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomas","family":"Tesar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lubica","family":"Hlinkova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Slavkovsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Aarnio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,8]]},"reference":[{"issue":"4","key":"772_CR1","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1111\/j.1532-5415.2007.01123.x","volume":"55","author":"Y Ostchega","year":"2007","unstructured":"Ostchega Y, Paulose-Ram R, Dillon CF, Gu Q, Hughes JP. Prevalence of peripheral arterial disease and risk factors in persons aged 60 and older: data from the National Health and Nutrition Examination Survey 1999\u20132004. J Am Geriatr Soc. 2007;55(4):583\u20139.","journal-title":"J Am Geriatr Soc"},{"issue":"5","key":"772_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1161\/JAHA.116.003796","volume":"6","author":"CA Kalbaugh","year":"2017","unstructured":"Kalbaugh CA, Kucharska-Newton A, Wruck L, et al. Peripheral Artery Disease Prevalence and Incidence Estimated from Both Outpatient and Inpatient Settings Among Medicare Fee-for-Service Beneficiaries in the Atherosclerosis Risk in Communities (ARIC) Study. J Am Heart Assoc. 2017;6(5):1.","journal-title":"J Am Heart Assoc."},{"key":"772_CR3","doi-asserted-by":"crossref","unstructured":"GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990\u20132013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;385(9963):117\u201371.","DOI":"10.1016\/S0140-6736(14)61682-2"},{"issue":"1","key":"772_CR4","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ccl.2014.09.010","volume":"33","author":"K Agrawal","year":"2015","unstructured":"Agrawal K, Eberhardt RT. Contemporary medical management of peripheral arterial disease: a focus on risk reduction and symptom relief for intermittent claudication. Cardiol Clin. 2015;33(1):111\u201337.","journal-title":"Cardiol Clin"},{"issue":"21","key":"772_CR5","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1056\/NEJM200105243442108","volume":"344","author":"WR Hiatt","year":"2001","unstructured":"Hiatt WR. Medical treatment of peripheral arterial disease and claudication. N Engl J Med. 2001;344(21):1608\u201321.","journal-title":"N Engl J Med"},{"issue":"4","key":"772_CR6","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.hlc.2017.10.014","volume":"27","author":"SM Conte","year":"2018","unstructured":"Conte SM, Vale PR. Peripheral arterial disease. Heart Lung Circ. 2018;27(4):427\u201332.","journal-title":"Heart Lung Circ"},{"issue":"25","key":"772_CR7","first-page":"e1082","volume":"139","author":"SM Grundy","year":"2019","unstructured":"Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;139(25):e1082\u2013e11431143.","journal-title":"Circulation"},{"issue":"5","key":"772_CR8","doi-asserted-by":"publisher","first-page":"430","DOI":"10.2174\/1570161115666170504124911","volume":"15","author":"P Kitrou","year":"2017","unstructured":"Kitrou P, Katsanos K, Karnabatidis D, Reppas L, Brountzos E, Spiliopoulos S. Current evidence and future perspectives on anti-platelet and statin pharmacotherapy for patients with symptomatic peripheral arterial disease. Curr Vasc Pharmacol. 2017;15(5):430\u201345.","journal-title":"Curr Vasc Pharmacol"},{"issue":"22","key":"772_CR9","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.1093\/eurheartj\/ehr211","volume":"32","author":"M Tendera","year":"2011","unstructured":"Tendera M, Aboyans V, Bartelink ML, et al. ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). Eur Heart J. 2011;32(22):2851\u2013906.","journal-title":"Eur Heart J"},{"issue":"4","key":"772_CR10","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s40266-018-00632-x","volume":"36","author":"S Yandrapalli","year":"2019","unstructured":"Yandrapalli S, Gupta S, Andries G, Cooper HA, Aronow WS. Drug therapy of dyslipidemia in the elderly. Drugs Aging. 2019;36(4):321\u201340.","journal-title":"Drugs Aging"},{"issue":"6","key":"772_CR11","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/S0002-9149(03)00833-6","volume":"92","author":"WS Aronow","year":"2003","unstructured":"Aronow WS, Nayak D, Woodworth S, Ahn C. Effect of simvastatin versus placebo on treadmill exercise time until the onset of intermittent claudication in older patients with peripheral arterial disease at six months and at one year after treatment. Am J Cardiol. 2003;92(6):711\u20132.","journal-title":"Am J Cardiol"},{"key":"772_CR12","doi-asserted-by":"crossref","unstructured":"De Geest S, Zullig LL, Dunbar-Jacob J, et al. Helmy R, Hughes DA, Wilson IB, Vrijens B. ESPACOMP Medication adherence reporting guideline (EMERGE). Ann Intern Med. 2018;169(1):30\u20135.","DOI":"10.7326\/M18-0543"},{"issue":"5","key":"772_CR13","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1111\/j.1365-2125.2012.04167.x","volume":"73","author":"B Vrijens","year":"2012","unstructured":"Vrijens B, De Geest S, Hughes DA, et al. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol. 2012;73(5):691\u2013705.","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"772_CR14","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s40256-016-0171-6","volume":"16","author":"KO Obamiro","year":"2016","unstructured":"Obamiro KO, Chalmers L, Bereznicki LR. A summary of the literature evaluating adherence and persistence with oral anticoagulants in atrial fibrillation. Am J Cardiovasc Drugs. 2016;16(5):349\u201363.","journal-title":"Am J Cardiovasc Drugs"},{"issue":"1","key":"772_CR15","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s40256-019-00356-2","volume":"20","author":"G Montalescot","year":"2020","unstructured":"Montalescot G, Brotons C, Cosyns B, et al. Educational impact on Apixaban adherence in atrial fibrillation (the AEGEAN STUDY): a randomized clinical trial. Am J Cardiovasc Drugs. 2020;20(1):61\u201371.","journal-title":"Am J Cardiovasc Drugs"},{"issue":"9","key":"772_CR16","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s40266-019-00689-2","volume":"36","author":"M Wawruch","year":"2019","unstructured":"Wawruch M, Wimmer G Jr, Murin J, et al. Patient-associated characteristics influencing the risk for non-persistence with statins in older patients with peripheral arterial disease. Drugs Aging. 2019;36(9):863\u201373.","journal-title":"Drugs Aging"},{"issue":"21","key":"772_CR17","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.1016\/j.jacc.2018.08.2191","volume":"72","author":"R Ofori-Asenso","year":"2018","unstructured":"Ofori-Asenso R, Ilomaki J, Tacey M, et al. Switching, discontinuation, and reinitiation of statins among older adults. J Am Coll Cardiol. 2018;72(21):2675\u20137.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"772_CR18","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.mayocp.2018.01.011","volume":"93","author":"R Ofori-Asenso","year":"2018","unstructured":"Ofori-Asenso R, Zoungas S, Liew D. Reinitiation of statin therapy after discontinuation: a meta-analysis. Mayo Clin Proc. 2018;93(5):665\u20138.","journal-title":"Mayo Clin Proc"},{"key":"772_CR19","doi-asserted-by":"publisher","first-page":"i3305","DOI":"10.1136\/bmj.i3305","volume":"353","author":"Y Vinogradova","year":"2016","unstructured":"Vinogradova Y, Coupland C, Brindle P, Hippisley-Cox J. Discontinuation and restarting in patients on statin treatment: prospective open cohort study using a primary care database. BMJ. 2016;353:i3305.","journal-title":"BMJ"},{"issue":"9","key":"772_CR20","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1007\/s00228-011-1019-2","volume":"67","author":"MJ Korhonen","year":"2011","unstructured":"Korhonen MJ, Helin-Salmivaara A, Huupponen R. Dynamics of long-term statin therapy. Eur J Clin Pharmacol. 2011;67(9):925\u201331.","journal-title":"Eur J Clin Pharmacol"},{"key":"772_CR21","first-page":"382","volume-title":"Biostatistical methods in epidemiology","author":"SC Newman","year":"2001","unstructured":"Newman SC. Biostatistical methods in epidemiology. Chichester: Wiley; 2001. p. 382."},{"issue":"5","key":"772_CR22","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.cjca.2012.03.018","volume":"28","author":"M Lemstra","year":"2012","unstructured":"Lemstra M, Blackburn D. Nonadherence to statin therapy: discontinuation after a single fill. Can J Cardiol. 2012;28(5):567\u201373.","journal-title":"Can J Cardiol"},{"issue":"8","key":"772_CR23","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1001\/archinte.167.8.847","volume":"167","author":"MA Brookhart","year":"2007","unstructured":"Brookhart MA, Patrick AR, Schneeweiss S, et al. Physician follow-up and provider continuity are associated with long-term medication adherence: a study of the dynamics of statin use. Arch Intern Med. 2007;167(8):847\u201352.","journal-title":"Arch Intern Med"},{"issue":"10","key":"772_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1161\/CIRCOUTCOMES.117.003626","volume":"10","author":"JN Booth 3rd","year":"2017","unstructured":"Booth JN 3rd, Colantonio LD, Chen L, et al. Statin discontinuation, reinitiation, and persistence patterns among medicare beneficiaries after myocardial infarction: a cohort study. Circ Cardiovasc Qual Outcomes. 2017;10(10):1.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"1","key":"772_CR25","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.amjopharm.2011.02.004","volume":"9","author":"WF Gellad","year":"2011","unstructured":"Gellad WF, Grenard JL, Marcum ZA. A systematic review of barriers to medication adherence in the elderly: looking beyond cost and regimen complexity. Am J Geriatr Pharmacother. 2011;9(1):11\u201323.","journal-title":"Am J Geriatr Pharmacother"},{"issue":"11","key":"772_CR26","doi-asserted-by":"publisher","first-page":"e0225390","DOI":"10.1371\/journal.pone.0225390","volume":"14","author":"SD Alfian","year":"2019","unstructured":"Alfian SD, Denig P, Coelho A, Hak E. Pharmacy-based predictors of non-adherence, non-persistence and reinitiation of antihypertensive drugs among patients on oral diabetes drugs in the Netherlands. PLoS ONE. 2019;14(11):e0225390.","journal-title":"PLoS ONE"}],"container-title":["Drugs & Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-020-00772-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40266-020-00772-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-020-00772-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,7]],"date-time":"2021-06-07T23:45:58Z","timestamp":1623109558000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40266-020-00772-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,8]]},"references-count":26,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["772"],"URL":"https:\/\/doi.org\/10.1007\/s40266-020-00772-z","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"value":"1170-229X","type":"print"},{"value":"1179-1969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,8]]},"assertion":[{"value":"8 June 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"This study was supported by a grant from the Scientific Grant Agency of the Ministry of Education, Science, Research and Sport of the Slovak Republic (VEGA 1\/0112\/17). EA has received funding from the Finnish Cultural Foundation. The providers of these grants played no role in study design, methodology, data collection, analysis and interpretation of the data, and preparation of the paper, or in the decision to submit the manuscript for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Martin Wawruch, Gejza Wimmer Jr, Jan Murin, Martina Paduchova, Tomas Tesar, Lubica Hlinkova, Peter Slavkovsky, and Emma Aarnio declare they have no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}